Dr. Lara on the Potential Role of IDO Inhibitors in the Treatment of RCC
August 1st 2017Primo N. Lara, MD, associate director for translational research, UC Davis Comprehensive Cancer Center, discusses the potential role of IDO inhibitors in the treatment of patients with renal cell carcinoma.
Read More